foxo4-dri peptide senolytic 2023 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI - 10mg - Ion
FOXO4 DRI 10mg Ion Peptide FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology FOXO4 DRI 10mg vial Description RCpeptides FOXO4 DRI (Proxofim) (10mg)
Pay in 4 interest-free payments of $6.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5





